cd38 inhibitor and 5-amino-1mq synergy nad+ Inhibition of enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism A systems-approach to NAD+ restoration
A systems approach to NAD+ restoration ScienceDirect Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome PMC The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





